BioHealth News Archive
Opportunities in the Eastern U.S. Life Sciences Clusters – Science Careers – Biotech, Pharmaceutical, Faculty, Postdoc jobs on Science Careers
For scientists pursuing careers in biotech, clusters of life science-related companies and research institutions in the eastern United States may be a promising place…
Read MoreBioBuzz Rockville – April 25. 2012
Join us on April 25th at Stella Restaurant for another BioBuzz in Montgomery County! This month's corporate sponsor, BioHealth Innovation, inc. (BHI) is an innovation intermediary that translates market-relevant research…
Read MoreGroup Set To Sequence 1000 Genomes By The End Of The Year | Singularity Hub
When the Human Genome Project got underway in 1990 it was expected to take 15 years to sequence the over 3 billion chemical base…
Read MoreSynthetic cells could be the future of drug delivery – FierceDrugDelivery
In the world of drug development, honing an effective molecule is just the first step. As everyone in the drug delivery business knows, issues…
Read MoreHamner: Biotech growth to last until 2035 – Triangle Business Journal
Dr. Charles Hamner has been researching the nanotechnology industry since, as he puts it, “before they called it nanotechnology.” But he says it’s not…
Read MoreCerecor, biotech startup headed by Blake Paterson, raises $22M – Baltimore Business Journal
Cerecor Inc., a Baltimore biotech startup headed by former Alba Therapeutics CEO Dr. Blake Paterson, has raised $22 million in a Series A financing…
Read MoreInvestMaryland VC firms to be recommended by London’s Altius Associates – Baltimore Business Journal
Maryland has chosen a London firm to oversee the selection of venture capital firms interested in making investments in young state companies through the…
Read MoreNIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH
Over the past decade, collaborative research efforts to support the discovery and development of medicines has increased dramatically. Last month, the National Institutes of…
Read MoreMedImmune central to AstraZeneca-Amgen antibody deal – Washington Business Journal
Pharmaceutical giants AstraZeneca PLC and Amgen Inc. just announced a deal to co-develop and co-commercialize five product candidates, all monoclonal antibodies. No surprise here: LLC …
Read MoreBiotech Can’t Sidestep Cost-Effectiveness Anymore | Xconomy
Back in the old days of biotech, the business was pretty straightforward. You’d craft your scientific idea, aim a new drug at patients in need,…
Read MoreWhat venture capitalists look for in personalized medicine investments
Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can guide personalized medicine. Bob…
Read MoreGene mapping isn’t a crystal ball for future health… yet – NY Daily News
Gene scans for everyone? Not so fast. New research suggests that for the average person, decoding your own DNA may not turn out to…
Read MoreEmergent’s Fuad El-Hibri, an entrepreneur at heart
Fuad El-Hibri has started a financial consulting business. He’s started telecommunications businesses. But his most challenging venture has been the Rockville biotech he helped…
Read MoreUNH Center for Venture Research: U.S. Angel Investor Market on Solid Path of Recovery in 2011
Following a considerable contraction in investment dollars in 2008 and 2009, the U.S. angel investor market continued to recover in 2011, a trend that…
Read MoreAstraZeneca links up with Amgen for treatments development
Shares in AstraZeneca ticked up after the Anglo-Swedish drugs giant announced a tie-up with biotechnology giant Amgen to develop and commercialise five treatments. Under…
Read More